NovoCure (NVCR) Long-Term Investments (2015 - 2018)

NovoCure (NVCR) has reported Long-Term Investments for 4 consecutive years, with $9.9 million the latest figure, recorded in Q4 2018.

• Quarterly Long-Term Investments rose 20.54% year-over-year to $9.9 million in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $9.9 million (up 20.54% YoY) and the FY2018 annual result came in at $9.9 million, up 20.54% from the prior year.
• Long-Term Investments advanced to $9.9 million in Q4 2018 per NVCR's latest filing, from $8.2 million in the prior quarter.
• Over the last five years, Long-Term Investments for NVCR reached as high as $9.9 million in Q4 2018 and fell as low as $4.4 million in Q4 2015.
• A 4-year average of $7.1 million and a median of $7.1 million in 2016 frame the typical range for Long-Term Investments.
• Annual changes were most pronounced in 2017 — Long-Term Investments soared 37.87% — and 2018, when it rose 20.54%.
• Year by year, Long-Term Investments stood at $4.4 million in 2015, then jumped by 34.87% to $6.0 million in 2016, then surged by 37.87% to $8.2 million in 2017, then advanced by 20.54% to $9.9 million in 2018.
• According to Business Quant data, Long-Term Investments over the past three periods registered $9.9 million, $8.2 million, and $6.0 million for Q4 2018, Q4 2017, and Q4 2016 respectively.